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ABSTRACT 
 
Impairments in spatial processing due to hippocampal degeneration have been observed in 
the years immediately preceding the diagnosis of Alzheimer’s Disease (AD) dementia. The 
demonstration of changes in spatial processing in preceding decades would provide a 
cognitive marker for pre-clinical AD and an outcome measure for early intervention trials. The 
present study examined allocentric and egocentric spatial processing in relation to future 
dementia risk in a middle-aged cohort. The CAIDE Dementia Risk Score (DRS) was 
calculated for 188 persons aged 40 to 59, of whom 94 had a parent with dementia. 
Participants underwent the Four Mountains Test (4MT) of allocentric spatial processing, the 
Virtual Reality Supermarket Trolley Task (VRSTT) of egocentric spatial processing and 3T 
MRI scans. A significant negative association was found between the DRS and 4MT 
(Spearman correlation -0.26, p=0.0006), but not with the VRSTT. The 4MT was also found to 
be a better predictor of risk than tests of episodic memory, verbal fluency or executive 
functioning. The results suggest that allocentric rather than egocentric processing may be a 
potential indicator of risk for late-onset AD, consistent with the hypothesis that the earliest 
cognitive changes in AD are driven by tau-related degeneration in the medial temporal lobe 
rather than amyloid-only deposition in the medial parietal lobe. 
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INTRODUCTION 
 
The universal failure to date of clinical trials aimed at slowing disease progression in patients 
with  Alzheimer’s disease (AD) related dementia has prompted increasing interest in the 
possibility of up-stream intervention at earlier, pre-dementia, phases of AD when treatments 
may be more effective. While biomarker studies suggest (AD) neuropathology to be present 
decades before the clinical diagnosis of dementia [1-3], the identification of functional 
markers, notably cognitive measures, indicative of incipient disease are more problematic. 
Such markers are, however, crucial for understanding the initial functional consequences of 
disease on the brain and for evaluating the effect of future treatments applied at the earliest 
stages of AD.  
 
Theoretical models of disease progression have suggested an absence of early cognitive 
changes in the pre-clinical period [4] however these models have been based on small 
samples using cognitive tests recommended for later-stage dementia diagnosis. A recent 
review of neuroimaging and prospective epidemiological studies has suggested that pre-
clinical alterations in cognitive function may exist, but detection would require the use of 
more sensitive and specific tests probing the function of brain regions first affected in AD [5]. 
As such, there is an increasing focus on the development of testing procedures suitable for 
the pre-clinical phase of AD that evaluate the functions of the hippocampus and related 
structures, given that these are the first regions to exhibit tau-related neurodegeneration in 
addition to amyloid accumulation [6-7].  
 
The known cognitive consequences of hippocampal cell loss are principally impairment in 
episodic memory and spatial information processing. Episodic memory has long been 
considered the central feature of cognitive impairment in AD dementia and although also 
observed in studies of pre-clinical AD [5], is not specific to hippocampal damage, but occurs in 
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the context of damage to other brain regions such as the frontal lobes, and is also present in 
non-AD. By comparison, spatial processing in AD has received relatively scant attention 
despite the discovery nearly 50 years ago that hippocampal neurons (place cells) exhibit 
spatially-modulated firing activity [8] and that place cell firing is coupled to spatial memory [9].  
Functional neuroimaging has subsequently shown that the human hippocampus is also 
involved in spatial processing, as a core part of a network of brain regions which also includes 
the entorhinal cortex, retrosplenial cortex and precuneus [10-12].  Indeed, there is well-
established strong structural and functional connectivity between these brain regions, 
suggesting that they might be an ideal neural and cognitive substrate for pre-clinical AD 
changes [13].  
Behavioural tests of spatial processing derived largely from cognitive and experimental 
psychology, have focused primarily on spatial orientation and memory in healthy persons and 
have only recently been applied to studies of hippocampal involvement in neurodegenerative 
disease. Bird et al. [14] found that performance on the Four Mountains Task (4MT) [15] of 
allocentric spatial memory was impaired in patients with early AD dementia, with a similar 
observation being made by Pengas et al. [16] in a study using several different tests of spatial 
memory. Crucially for the study of AD in its earlier stages, Moodley et al. [17] found that 
performance on the 4MT was not only able to discriminate patients with mild cognitive 
impairment (MCI) from age-matched controls, but was also able to differentiate MCI patients 
with and without cerebrospinal fluid (CSF) biomarker evidence of underlying AD . Notably, this 
differentiation of MCI groups at higher and lower risk of developing AD dementia using 
currently recognized biomarkers [18] was not achieved using the Rey Auditory Verbal Learning 
Test and the Trail Making Test both of which are considered sensitive to early AD and therefore 
included in the FDA-recommended Pre-Alzheimer Cognitive Composite battery for use in 
preclinical AD trials [20]. Impairment of allocentric spatial processing in people at risk of AD 
dementia has also been shown with a variety of other tasks, ranging from the demonstration 
of reduced fMRI activation of the entorhinal cortex associated with altered navigational 
behaviour in young adult APOE-e4 carriers [21] and deficient virtual way-finding in people with 
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preclinical AD [22] through to use of real world navigation tasks to identify spatial impairments 
in patients with MCI [23]). A systematic review across multiple methods has concluded that 
deficits of allocentric spatial processing occur from the earliest stages of AD [24]. 
One complication, however, with allocentric spatial memory tests is that they rely on intact 
episodic memory processes to be completed. As outlined above, some of these tests have 
been shown to outperform existing non-spatial episodic memory tests, while others have not 
[16]. In particular, non-verbal episodic memory tests (eg. Rey Figure, PAL) have often shown 
to have similar sensitivity and specificity to spatial memory tests [16]. A different approach is 
to tap into egocentric spatial navigation processes, which rely much less on episodic memory 
intactness and targeting more specifically retrosplenial and precuneus brain areas [25]. The 
Virtual Reality Supermarket Trolley Task (VRSTT) [26] is, to our knowledge, the only clinically 
available test to tap into egocentric spatial orientation. The VRSTT has been shown to correlate 
with retrosplenial/precuneus atrophy in AD and also distinguishes AD from other 
neurodegenerative conditions with hippocampal atrophy (ie. bvFTD, sv-PPA) [26]. A more 
recent version of the VSRTT has also shown that egocentric and allocentric spatial orientation 
can be dissociated by the test [26], further highlighting the need for tests which tap into allo- 
and egocentric processing to reliably differentiate spatial navigation deficits in preclinical and 
symptomatic AD.  
 
Preliminary evidence thus suggests that tests of spatial processing may provide more 
sensitive outcome measures than currently used cognitive tests. However, the preclinical 
phase of AD may cover several decades, and at present little is known on either the 
sensitivity of such tests to early brain changes during this period, or at what distance from 
dementia onset such change might first be detected. To test the hypothesis that spatial 
processing is affected in preclinical AD, the present study tested a cohort of 40-59 year old 
individuals at risk of developing late onset dementia within the pilot phase of the PREVENT 
Dementia cohort study [20]. Two types of spatial processing were examined: (i) person-
independent  allocentric processing, considered to be subserved primarily by the 
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hippocampus, which relates to the encoding of information about the location of objects in 
relation to other objects external to the self,  and (ii) person-dependent egocentric 
processing, primarily reflecting the function of medial parietal lobe regions [17], encoding the 
location of objects relative to the body axes of the self (left/right front/back up/down). Given 
that cognitive impairment is correlated with tau pathology, and that tau-related 
neurodegeneration is observed in the hippocampus prior to the medial parietal lobe, the 
study prediction was that increased dementia risk in the preclinical phase would be 
associated more with allocentric spatial processing than egocentric spatial processing. In this 
study dementia risk is defined according to a previously validated dementia risk score 
combining genetic and cardiovascular risk factors.  
 
 
MATERIALS AND METHODS 
 
Subjects 
The PREVENT Dementia Programme is a prospective multi-site study of the adult children 
(40 to 59 years of age at recruitment) of persons with dementia, and an equal number of 
those without a parent with dementia who are in the same age band. The study is designed 
to identify clinical and biological changes in the pre-clinical phase of AD which may 
subsequently be used as short-term outcome measures for mid-life secondary preventions. 
The protocol for the PREVENT Dementia study has been described in detail elsewhere [19]. 
For the purposes of the present research only the results from one PREVENT study site 
(West London) were used, as this is currently the only site for which spatial testing and 
genotyping have been completed for all participants. West London participants were 
recruited through multiple sources including the dementia register (DemReg) database held 
at West London Mental Health NHS Trust (WLMHT), the Join Dementia Research website 
(https://www.joindementiaresearch.nihr.ac.uk/), and also by information about the study 
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through the internet and public presentations. Of the 188 persons included, 175 (124 women, 
51 men) had complete cognitive data, and of these 94 have at least one parent with a 
dementia diagnosis, referred to as the family history (FH sub-group). One hundred and thirty 
two participants were 50 years or over, and 43 under 50. 
Consent and organisation of examinations 
Consented participants were seen at the West London Cognitive Disorders Treatment and 
Research Unit, where they were given a standardized neuropsychiatric interview and life-
style questionnaires. Blood was taken for ApoE genotyping with all members of the research 
and clinical teams remaining blind to the result. Approval for the study was given by the NHS 
Research Ethics Committee, London, Camberwell St-Giles.  
(i) Allocentric processing  
Allocentric processing was evaluated using the Four Mountains Task (4MT) [15] using the 
spatial memory score rather than processing speed, the latter not being available for all 
participants. This test consists of computer-generated landscapes, each featuring four 
mountains of different shapes and sizes. Subjects are asked to look at a landscape image for 
8 seconds. After a 2 second delay they are asked to identify the previous-viewed landscape, 
but seen from a different viewpoint, from a selection of four landscapes (ie three foil images) 
presented simultaneously in 2x2 configuration (see Figure). Participants are given 30 
seconds to choose; a lack of response after this time is allocated a zero score. Non-spatial 
features (lighting, vegetation colour, cloud cover) of both target and foil landscapes are 
varied between presentation and testing, such that non-spatial features of the image cannot 
be relied on to solve the task. The test is presented on an electronic tablet (Apple iPad) and 
subjects respond by touching their selected image on the tactile screen. All participants 
undergo three practice trials in order to ensure comprehension of the task , with the test 
proper consisting of 15 trials. The final test score was calculated as the number of correctly 
identified landscapes (maximum score 15).   
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(ii) Egocentric processing  
In PREVENT Dementia it is assessed by the Virtual Reality Supermarket Trolley Task (VRST) 
[26] which involves presentation of 14 video vignettes within a simulated supermarket 
presented on a tablet (Apple iPad) and seen from a first person perspective. From the entrance 
participants follow a route through the supermarket which involves a series of 90° turns after 
which the subject is required to point towards the entrance. The response is recorded 
according to a theoretical quadrant (upper and lower left, upper and lower right). The number 
of correct locations (left or right upper quadrant or left or right lower quadrant) are recorded as 
well as error type. The score range is 0-14. 
In order to compare the performance of these tests with other cognitive tests commonly used 
in preclinical and prodromal research, associations with DRS were also examined in relation 
to visual and verbal episodic memory (immediate and delayed recall of names and faces), 
executive functioning (progressive matrices test of visual reasoning) and lexical access (verbal 
fluency). These tests, taken from the COGNITO Battery and their administrative procedures 
within the PREVENT Dementia protocol are described in detail elsewhere [19]. 
Imaging 
All participants underwent 3T MRI scanning on a single scanner (Siemans Verio) including 
whole brain T1-weighted scans (176 slices, 1.0 x 1.0 mm, 1.0 mm slice thickness, TR = 
2300ms, TE = 2.98ms, flip angle 9°) up to two years before the cognitive testing. Brain tissue 
segmentation into grey matter (GM), white matter (WM) and cerebrospinal fluid (CSF) was 
performed using the Gaussian mixture model in VBM toolbox of SPM8 
(http://www.fil.ion.ucl.ac.uk/spm). The GM maps were then normalized using the DARTEL 
algorithm [27]. Hippocampal region of interests (ROIs) were selected using AAL atlas in MNI 
space [28], and then inverse normalized back to each subject’s native space using the 
participant-specific diffeomorphic parameters estimated from the previous DARTEL 
9 
 
procedure. The resulting ROIs were also masked using the thresholded GM probability maps 
(at threshold p > 0.8) before the total hippocampal volume was calculated. To control for 
inter-individual differences in head size, the hippocampal volumes are given as a proportion 
of the estimated total intracranial volume (ICV). 
Genotyping 
Taqman Genotyping was carried out in a single laboratory on QuantStudio12K Flex to 
establish ApoE variants. Genomic DNA was isolated from whole blood and genotyping was 
performed in 384 well-plates, using the TaqMan polymerase chain reaction-based method. 
The final volume PCR reaction was 5 μl using 20 ng of genomic DNA, 2.5 μl of Taqman 
Master Mix and 0.125μl of 40x Assay By design Genotyping Assay Mix, or 0.25µl of 20x 
Assay On Demand Genotyping Assay. The cycling parameters were 95° for 10 minutes, 
followed by forty cycles of denaturation at 92° for 15 seconds and annealing/extension at 60° 
for 1 minute. PCR plates were then read on ThermoFisher QuantStudio 12K Flex Real Time 
PCR System instrument with QuantStudio 12K Flex Software or Taqman Genotyper 
Software v1.3.  
 
Statistical analyses  
 
Dementia Risk Scores (DRS) were calculated for each participant irrespective of family history 
of dementia using the CAIDE score [30]. This is a risk score validated within prospective 
population studies and demonstrated to predict dementia onset up to 40 years before diagnosis 
[30]. It is composed of cohort-based weightings by reference to the following variables: age, 
education, sex, systolic blood pressure, body mass index, total cholesterol, physical activity, 
ApoE status. These sub-scores were derived from the PREVENT clinical examinations in the 
same way as for the Kivipelto et al. study of mid-life prediction of dementia [29]. Scores vary 
from 0 to 15 and are treated as a continuous variable in the present analyses.  
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Comparisons of sociodemographic characteristics and prevalent pathologies between FH and 
non FH groups were performed using Chi square tests for categorical variables and Wilcoxon 
two-sample tests for continuous variables. As Box Cox analyses were unable to establish 
potential non-linear distributions, linear regression models were used to compare the 4MT 
score with other participant characteristics, while unpaired Wilcoxon tests were used for the 
Supermarket Trolley test score owing to its highly skewed distribution.  Comparisons of 
sociodemographic characteristics and prevalent pathologies between FH and non FH groups 
were performed using Chi square tests for categorical variables and Wilcoxon two-sample 
tests for continuous variables. Spearman correlation coefficients for continuous characteristics 
and unpaired Wilcoxon tests for categorical characteristics were used to compare the 4MT 
score and the supermarket test with other participant characteristics. In order to make a more 
direct comparison between the 4MT and Supermarket Trolley tests, as well as with other tests 
commonly used to test preclinical and prodromal persons, the DRS mean score was also 
compared with tertiles of cognitive tests from the COGNITO battery (immediate recall of a 
name list, delayed face recall, delayed name recall, progressive matrices, verbal fluency, 
allocentric and egocentric spatial performances) using one way analysis of variance. 
 
RESULTS 
The age, socio-economic status and gender distributions of the participants are given in 
Table 1, comparing those with and without a family history (FH) of dementia 
Persons with a family history of dementia were found to have a lower level of education, a 
higher prevalence of the ApoE 4 allele, and to have a significantly higher dementia risk 
score (DRS) than controls (mean (SD) of 7.10 (2.66) vs 5.85 (2.91), p=0.003). No association 
was found between the CAIDE dementia risk score and total brain or hippocampal volume. 
 
Table 1 here 
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Associations between the two tests in relation to participant characteristics are given in Table 
2 and score distributions in Figure 1.  
 
Table 2 here 
Figure 1 here 
Allocentric processing 
4MT scores were calculated as the sum of correct responses in participants without missing 
data . A significant positive association was found between 4MT scores and number of years 
of education (Spearman correlation 0.23; p=0.02) and a significant negative association 
between 4MT and dementia risk score (DRS) (Spearman correlation -0.26; p=0.0006). 
Table 2 here  
Within a univariate linear regression model (Table 2) the 4MT score was found to be 
significantly associated with age, family history of dementia, years of education and the DRS, 
but not with gender and ApoE 4 status alone. Within a multivariate model adjusted for age 
and education, the association between 4MT score and family history became non-significant 
(p=0.11). No association was found with history of head injury. On structural MRI imaging no 
association was found between 4MT score and either total brain volume or total hippocampal 
volume.  
Egocentric processing 
Supermarket test performance was calculated as the total number of correctly designated 
quadrants (Figure 2). Women were found to have lower scores than men (unpaired Wilcoxon 
test p=0.002) and persons under 50 higher scores than those over 50 (unpaired Wilcoxon 
test p=0.04). A high positive association was also found with education (unpaired Wilcoxon 
test= 0.0003). No significant association was found between test scores and the DRS, history 
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of head trauma or family history, ApoE 4 status or structural MRI measures (total brain and 
total hippocampal volume). 
Scatterplots showing the association (regression line and 95% confidence band) between 
4MT and the Supermarket Trolley test with the DRS are given in Figure 2. 
Figure 2 here 
Given the skewed distribution of the Supermarket Trolley test it was not possible to compare 
them within a multivariate model. We therefore divided the scores of both tests into tertiles 
for a more direct comparison of their performance in relation to the DRS. We also converted 
the scores of the COGNITO tests into tertiles to comparetheir association their association 
with DRS to that of the spatial tasks. The results are given in Table 3. 
Table 3 here 
 
DISCUSSION 
Given that preclinical AD neurodegeneration is observed at an early stage in the 
hippocampus and related medial temporal lobe (MTL) structures, the role of these regions in 
the processing of spatial information suggests that impaired performance on spatial tests 
may represent an early behavioural marker of AD-related brain changes. This is supported 
by longitudinal MRI studies of AD showing that altered performance on visuospatial tasks 
predates MTL atrophy in preclinical cases [31].  
Within this middle-aged cohort, 54% have a parent diagnosed with dementia. On the basis of 
research indicating an association between age of onset in parents and age of diagnosis in 
offspring in both early-onset AD [32] and late-onset cases [33-34], we previously estimated 
persons with a family history of dementia in this cohort to be at a mean distance from 
dementia diagnosis of 24 years (SD 7.5) [35]. This suggests any future cases to be within a 
pre-clinical period. Family history is, however, an insufficient basis for defining dementia risk, 
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so for this study we have calculated the CAIDE dementia risk score for all participants, as 
this algorithm combining the principal genetic risk of an ApoE 4 allele with cardiovascular 
risk factors, has previously been found to predict dementia on average 36 years before 
diagnosis. The CAIDE score was also found to predict white matter hyperintensity volume 
and hippocampal volume on an average of 17 years before diagnosis [36]. While previous 
studies have shown a cross-sectional relationship between CAIDE dementia risk score and 
brain volume changes in the prodromal period [36], this was not observed in preceding 
decades [37].  
Performance on the delayed match-to-sample 4MT of allocentric spatial processing was not 
associated with family history of dementia, or the ApoE e4 allele. However, a significant 
association was observed between 4MT score and the CAIDE dementia risk score, although 
the correlation coefficient was quite small. In contrast, no association was observed between 
performance on the VR Supermarket Trolley Test of egocentric spatial memory/processing 
and DRS, ApoE4, FH, brain or hippocampal volume. It is possible, however, that the positive 
skew of the egocentric processing test has given rise to lower sensitivity to mild decrements, 
as compared to the normal distribution of the allocentric test. Increases in cohort size over 
time may yield a less skewed distribution which would allow us to better examine this point.  
Women were found to have a significantly lower score on egocentric processing than men, 
with no difference being observed for allocentric processing. This observation is coherent 
with previous studies suggesting that women tend to have more of a landmarkbased strategy 
while men utilise both landmark-based and global navigation strategies [37]. 
 
In order to make a more direct comparison of the two tests in relation to the risk score, we 
divided scores from both tests plus tests taken from the COGNITO battery commonly used in 
preclinical studies, into tertiles. Although this could potentially have lowered the association 
for 4MT, we found that the differential discrimination of the two tests remained. No 
relationship was found between the CAIDE dementia risk score and either the Supermarket 
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Trolley test, a test of immediate verbal recall, a progressive matrices test of executive 
functioning, delayed visual recall or verbal fluency. Only delayed verbal recall following 
interference tasks reached a low level of significance, whereas the 4MT showed a far 
stronger association.  
At this time, estimated on average to be around 24 years prior to possible dementia 
diagnosis in persons with a familial risk, there was no evidence of an association between 
the CAIDE dementia risk score and structural changes in the total brain or total hippocampal 
volume. This is consistent with longitudinal findings from the CAIDE study [37]. 
Within a previous report on cognitive performance within this cohort carried out two years 
before, we found no association between commonly used tests of episodic memory and 
either the CAIDE dementia risk score or other dementia risk factors, although a test for recall 
of the relative location of objects, a test implicating, although not specific to, allocentric 
spatial memory, was found to be associated with total hippocampal volume [35].  
Taken together, at this very early age and distance from possible dementia onset, our data 
indicate that allocentric, but not egocentric, spatial processing may be an important cognitive 
feature of risk for late onset AD. This is supportive of the study hypothesis and is consistent 
with theories of hippocampal function relating to its role in allocentric spatial processing [38]. 
These findings also align with the observations of Laukka et al. [39] who found that 
visuospatial deficits preceded changes in episodic and semantic memory for ten years before 
dementia diagnosis.  
One tentative conclusion to be drawn at this stage, but one in line with our a priori hypothesis 
and prediction, is that a test based on the function of the hippocampus, one of the brain 
regions initially affected by tau-related neurodegeneration, is a more sensitive cognitive 
marker of future dementia risk than a test probing the function of medial parietal regions 
associated with early amyloid but not early tau deposition. This preliminary conclusion would 
be consistent with the hypothesis that it is the tau, not amyloid spread that best predicts 
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cognitive decline in AD.  An alternative explanation of the relationship between CAIDE and 
allocentric spatial processing may be that CAIDE is detecting vascular changes occurring 
more in the hippocampus than the medial parietal areas independently of AD processes, 
although recent research suggests that such changes may in themselves be triggering AD 
tau accumulation independently of A [40].  
These results represent the first set of data from one PREVENT Dementia study site, and will 
be followed up by completion of spatial tests for the entire PREVENT Dementia cohort 
across five sites (West London, Cambridge, Oxford, Edinburgh and Dublin), with attendant 
increases in the power of the study. If these findings are supported by larger scale testing, 
then they have significant implications for clinical and translational AD research. First, they 
would support the existing case for including allocentric spatial memory tests in cognitive 
batteries aimed at preclinical AD [41], both to aid stratification of at-risk individuals into 
interventional studies and to use as outcome measures to evaluate the effect of interventions 
aimed at this early stage of AD.  
Two limitations of the present study are first the use of the CAIDE score as a proxy of AD risk 
given that very long term follow-up to clinical diagnosis is not feasible. This score may pick 
up other forms of dementia and not be specific to AD. Kivipelto et al. [29] found from 
prospective follow-up that 79% of the predicted cases were AD. A second limitation is its 
cross-sectional design, previous cross-sectional studies of pre-clinical AD having shown 
virtually no association between cognitive performance and brain changes [42-43]. Follow-up 
of the PREVENT Dementia cohort will permit examination of spatial memory performance 
across time and also in relation to not only brain volume but also functional changes and 
increases in amyloid load as well as associations with fixed and modifiable risks for 
neurodegeneration. Prospective data will allow us to develop longitudinal disease models 
and determine changes in test scores over time that are associated with increased dementia 
risk. Finally, the use of tests based on the discovery of hippocampal place cells in rodents 
provides a bridge between studies of AD in mouse models, which use the Morris Water Maze 
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and other spatial memory tests to measure pathology-associated behavior change and effect 
of pharmacological intervention, and studies of cognition in human populations. The 
identification of outcome measures to assess treatment effect that are comparable across 
preclinical and clinical trial phases will address one of the current major unresolved issues in 
AD research. 
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TABLE 1. Participant characteristics  
 Non FH  
N=81 
% 
FH 
N=94 
% 
Chi2 
p value 
Gender (women) 70.4 71.3 0.90 
Race (white) 92.6 88.3 0.34 
Education (n=174) 
post-graduate (6) 
trade or technical skills college  
Colleges/university   
high school (3) 
 
40.0 
17.5 
25.0 
17.5 
 
24.5 
7.4 
40.4 
27.7 
0.008 
Hypertension*  12.4 20.2 0.16 
Depressive symptoms† 18.5 16.0 0.65 
Diabetes  1.2 5.3 0.14 
Head injury (loss of consciousness) 
1-2 times 
3 times or more 
 
32.1 
6.2 
 
36.2 
4.3 
0.76 
ApoE ε4 allele (n=208) 30.9 46.7 0.03 
 median (IQR) median (IQR) Wilcoxon test 
p-value 
Age (years) 54.2 (47.4-58.2) 55.3 (51.7-58.3) 0.24 
Body mass index (kg/m2) 26.1 (23.4-29.9) 27.6 (23.7-31.6) 0.20 
* hypertension: treated or blood pressure >140/90 mmHg 
† Center for Epidemiologic Studies-Depression scale (CES-D) ≥ 16 
FH: Family history of dementia
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TABLE 2: associations of the Four Mountain score and the Supermarket test score with participant characteristics, n=175 
 
 Four Mountain test Supermarket Test 
 N Spearman correlation 
coefficient 
P value N Spearman correlation 
coefficient 
P value 
Age (years) 175 -0.19 0.01 172 -0.05 0.52 
Years of education 175 0.22 0.004 172 0.27 0.0003 
Dementia risk score  169 -0.25 0.0009 166 -0.02 0.78 
Brain/ ICV  in %  167 0.14 0.07 164 0.01 0.90 
Hippocampus/ ICV in %  167 0.02 0.76 164 -0.03 0.71 
Blows to head with LOC 175 0.004 0.96 172 -0.04 0.59 
  Median (IQR) P value*  Median (IQR) P value* 
Gender  
 Men 
 Women 
175  
11 (8-12) 
10 (7-12) 
0.05 172  
11 (10-12) 
10 (8-12) 
0.005 
FH of dementia 
 No 
 yes 
175  
10 (8-12) 
10 (7-11) 
0.05 172  
11 (9-12) 
10 (8-12) 
0.62 
24 
 
ApoE ε4  
 No 
 Yes 
172  
10 (8-12) 
10 (8-11) 
0.27 170  
10 (8-12) 
11 (9-12) 
0.47 
* Wilcoxon two-sample test 
 
ICV: Intra cranial volume, LOC: loss of consciousness 
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TABLE 3: unadjusted associations between cognitive test and Dementia Risk Score 
 DRS mean (SD) P value 
One way 
ANOVA 
2 by 2 
comparisons* 
Face Recall, (number of faces correctly 
recognised), n=166 
 T1 
 T2 
 T3 
 
 
6.72 (0.41) 
6.58 (0.32) 
6.34 (0.44) 
0.82  
Name Recall, (number of correct answers), 
n=166 
 T1 
 T2 
 T 
 
 
7.23 (0.43) 
6.49 (0.30) 
5.91 (0.47) 
0.12  
Name Recall, (number of names correctly 
recalled), n=166 
 T1 
 T2 
 T3 
 
 
7.33 (0.42) 
6.61 (0.35) 
5.92 (0.36) 
0.04 T1 vs T3 
p=0.03 
Matrix, (number of correct answers), n=166 
 T1 
 T2 
 T3 
 
 
7.00 (0.35) 
6.59 (0.50) 
6.15 (0.33) 
0.23  
Matrices, (total time), n=166 
 T1 
 T2 
 
6.75 (0.38) 
6.75 (0.37) 
0.46  
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 T3 6.17 (0.38) 
Verbal fluency, (number of correct answers), 
n=166 
 T1 
 T2 
 T3 
 
 
6.80 (0.40) 
6.29 (0.34) 
6.68 (0.41) 
0.59  
Four Mountain score, n=169 
 T1 
 T2 
 T3 
 
7.33 (0.37) 
6.88 (0.33) 
5.08 (0.39) 
<0.0001 T1 vsT3 
p=0.0001 
T2 vs T3 
p=0.002 
Supermarket score, n=166 
 T1 
 T2 
 T3 
 
6.64 (0.37) 
6.29 (0.36) 
6.52 (0.38) 
0.79  
* Bonferroni adjusted p-values 
DRS: Dementia risk score 
SD: standard deviation, T1 first tertile, T2 second tertile, T3 third tertile.  
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Figure 1: Distribution of the Four Mountain Score (n=175) and Supermarket Trolley score (n=172) 
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Figure 2: Scatterplot of the association of the Four Mountain (4MT) score and Supermarket Trolley 
score and the Dementia risk score (DRS) with the regression line and 95% confidence band 
 
 
 
